European journal of pain (London, England)
Nov 10, 2024
BACKGROUND AND OBJECTIVE: While the development of artificial intelligence (AI) technologies in medicine has been significant, their application to acute and chronic pain management has not been well characterized. This systematic review aims to prov...
European journal of pain (London, England)
Oct 3, 2024
BACKGROUND: The public release of ChatGPT in November 2022 sparked a boom and public interest in generative artificial intelligence (AI) that has led to journals and journal families hastily releasing generative AI policies, ranging from asking autho...
European journal of pain (London, England)
Apr 6, 2022
BACKGROUND: Pain intensity evaluation by self-report is difficult and biased in non-communicating people, which may contribute to inappropriate pain management. The use of artificial intelligence (AI) to evaluate pain intensity based on automated fac...
European journal of pain (London, England)
Nov 3, 2020
BACKGROUND: In pain research and clinics, it is common practice to subgroup subjects according to shared pain characteristics. This is often achieved by computer-aided clustering. In response to a recent EU recommendation that computer-aided decision...
European journal of pain (London, England)
Jul 13, 2018
BACKGROUND: Human genetic research has implicated functional variants of more than one hundred genes in the modulation of persisting pain. Artificial intelligence and machine-learning techniques may combine this knowledge with results of genetic rese...
European journal of pain (London, England)
Jan 16, 2018
BACKGROUND: Pain in response to noxious cold has a complex molecular background probably involving several types of sensors. A recent observation has been the multimodal distribution of human cold pain thresholds. This study aimed at analysing reprod...
European journal of pain (London, England)
Dec 20, 2017
BACKGROUND: Conditioned pain modulation (CPM) is a validated measure of the function of endogenous pain inhibitory pathways. Placebo effects reflect top-down inhibitory modulation of pain. CPM and placebo effects are both influenced by expectations, ...
European journal of pain (London, England)
Jun 11, 2015
BACKGROUND: Opioids are used for the treatment of pain. However, 30-50% of patients have insufficient effect to the opioid initially selected by the physician, and there is an urgent need for biomarkers to select responders to the most appropriate dr...
European journal of pain (London, England)
May 1, 2025
BACKGROUND: Pain-related conditions are the leading cause of years lived with disability globally. Managing pain presents significant challenges, including the need to address multiple biopsychosocial factors and the difficulty in delivering evidence...
European journal of pain (London, England)
Mar 1, 2025
BACKGROUND: Recurrence is common in chronic low back pain (CLBP). However, predicting the recurrence risk remains a challenge. The aim is to develop and validate a machine learning tool to predict the recurrence risk in patients with CLBP by using mu...